Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

698 public trials 151 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

NCT00054886

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +8 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Mission Hills, California, United States
  • Pfizer Investigational Site Monterey Park, California, United States
  • Pfizer Investigational Site Northridge, California, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

NCT03693014

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +25 more
Locations
  • Hartford Healthcare Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)

NCT05468697

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Georgetown University Medical Center ( Site 1002) Washington D.C., District of Columbia, United States
  • University of Chicago Medical Center ( Site 1007) Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center-Cancer Clinical Trials Office ( Site 1001) Boston, Massachusetts, United States
  • Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 1004) Salt Lake City, Utah, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Savolitinib vs. Sunitinib in MET-driven PRCC.

NCT03091192

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 59 locations
View Trial Details

Related conditions